Stockpolly
Search
INDP · NASDAQ · Biotechnology

Indaptus Therapeutics (INDP)

Develops systemically administered bacterial immunotherapy for cancer and antiviral applications.

$1.16
Pre-market+0.01 (+1.08%)
At close$1.15(+1.33%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
444434543822
Research & development222212322300
222222221521
General & administrative222222221521
Operating income−4−4−4−4−3−4−5−4−3−8−2−2
0000000−10000
Other non-operating income000000010000
Income before tax−4−4−4−4−3−4−5−5−3−8−3−2
Net income from continuing operations−4−4−4−4−3−4−5−5−3−8−3−2
Net income−4−4−4−4−3−4−5−5−3−8−3−2
EPS, basic−$0.47−$13.34−$12.63−$13.16−$9.04−$10.43−$9.00−$9.10−$2.98−$3.74−$0.23−$0.02
EPS, diluted−$0.47−$13.34−$12.63−$13.16−$9.04−$10.43−$9.00−$9.10−$2.98−$3.74−$0.23−$0.02
Weighted average shares, basic800000111211116
Weighted average shares, diluted800000111211116
EBITDA−4−4−4−4−3−4−5−5−3−8−3−2
Depreciation & amortization000000000000
EBIT−4−4−4−4−3−4−5−5−3−8−3−2